Human mesenchymal stem cells attenuate early damage in a ventilated pig model of acute lung injury

Yuben Moodley, Marian Sturm, K. Shaw, C. Shimbori, Dino Tan, M. Kolb, R. Graham

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

© 2016 The Authors. Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a major cause of global morbidity and mortality. Mesenchymal stem cells (MSC) have shown promise in treating inflammatory lung conditions. We hypothesised that human MSC (hMSC) can improve ALI/ARDS through their anti-inflammatory actions. We subjected pigs (n = 6) to intravenous oleic acid (OA) injury, ventilation and hMSC infusion, while the controls (n = 5) had intravenous OA, ventilation and an infusion vehicle control. hMSC were infused 1 h after the administration of OA. The animals were monitored for additional 4 h. Nuclear translocation of nuclear factor-light chain enhancer of activated B cells (NF-κB), a transcription factor that mediates several inflammatory pathways was reduced in hMSC treated pigs compared to controls (p = 0.04). There was no significant difference in lung injury, assessed by histological scoring in hMSC treated pigs versus controls (p = 0.063). There was no difference in neutrophil counts between hMSC-treated pigs and controls. Within 4 h, there was no difference in the levels of IL-10 and IL-8 pre- and post-treatment with hMSC. In addition, there was no difference in hemodynamics, lung mechanics or arterial blood gases between hMSC treated animals and controls. Subsequent studies are required to determine if the observed decrease in inflammatory transcription factors will translate into improvement in inflammation and in physiological parameters over the long term.
Original languageEnglish
Pages (from-to)25-31
JournalStem Cell Research
Volume17
Issue number1
DOIs
Publication statusPublished - 2016

Fingerprint

Acute Lung Injury
Mesenchymal Stromal Cells
Swine
Oleic Acid
Adult Respiratory Distress Syndrome
Ventilation
Transcription Factors
Lung
Lung Injury
Mechanics
Interleukin-8
Interleukin-10
Neutrophils
B-Lymphocytes
Anti-Inflammatory Agents
Gases
Hemodynamics
Inflammation
Morbidity
Light

Cite this

Moodley, Yuben ; Sturm, Marian ; Shaw, K. ; Shimbori, C. ; Tan, Dino ; Kolb, M. ; Graham, R. / Human mesenchymal stem cells attenuate early damage in a ventilated pig model of acute lung injury. In: Stem Cell Research. 2016 ; Vol. 17, No. 1. pp. 25-31.
@article{2db7e8a6ad134708a98f5cf1c286e71b,
title = "Human mesenchymal stem cells attenuate early damage in a ventilated pig model of acute lung injury",
abstract = "{\circledC} 2016 The Authors. Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a major cause of global morbidity and mortality. Mesenchymal stem cells (MSC) have shown promise in treating inflammatory lung conditions. We hypothesised that human MSC (hMSC) can improve ALI/ARDS through their anti-inflammatory actions. We subjected pigs (n = 6) to intravenous oleic acid (OA) injury, ventilation and hMSC infusion, while the controls (n = 5) had intravenous OA, ventilation and an infusion vehicle control. hMSC were infused 1 h after the administration of OA. The animals were monitored for additional 4 h. Nuclear translocation of nuclear factor-light chain enhancer of activated B cells (NF-κB), a transcription factor that mediates several inflammatory pathways was reduced in hMSC treated pigs compared to controls (p = 0.04). There was no significant difference in lung injury, assessed by histological scoring in hMSC treated pigs versus controls (p = 0.063). There was no difference in neutrophil counts between hMSC-treated pigs and controls. Within 4 h, there was no difference in the levels of IL-10 and IL-8 pre- and post-treatment with hMSC. In addition, there was no difference in hemodynamics, lung mechanics or arterial blood gases between hMSC treated animals and controls. Subsequent studies are required to determine if the observed decrease in inflammatory transcription factors will translate into improvement in inflammation and in physiological parameters over the long term.",
author = "Yuben Moodley and Marian Sturm and K. Shaw and C. Shimbori and Dino Tan and M. Kolb and R. Graham",
year = "2016",
doi = "10.1016/j.scr.2016.05.005",
language = "English",
volume = "17",
pages = "25--31",
journal = "Stem Cell Research",
issn = "1873-5061",
publisher = "Pergamon",
number = "1",

}

Human mesenchymal stem cells attenuate early damage in a ventilated pig model of acute lung injury. / Moodley, Yuben; Sturm, Marian; Shaw, K.; Shimbori, C.; Tan, Dino; Kolb, M.; Graham, R.

In: Stem Cell Research, Vol. 17, No. 1, 2016, p. 25-31.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Human mesenchymal stem cells attenuate early damage in a ventilated pig model of acute lung injury

AU - Moodley, Yuben

AU - Sturm, Marian

AU - Shaw, K.

AU - Shimbori, C.

AU - Tan, Dino

AU - Kolb, M.

AU - Graham, R.

PY - 2016

Y1 - 2016

N2 - © 2016 The Authors. Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a major cause of global morbidity and mortality. Mesenchymal stem cells (MSC) have shown promise in treating inflammatory lung conditions. We hypothesised that human MSC (hMSC) can improve ALI/ARDS through their anti-inflammatory actions. We subjected pigs (n = 6) to intravenous oleic acid (OA) injury, ventilation and hMSC infusion, while the controls (n = 5) had intravenous OA, ventilation and an infusion vehicle control. hMSC were infused 1 h after the administration of OA. The animals were monitored for additional 4 h. Nuclear translocation of nuclear factor-light chain enhancer of activated B cells (NF-κB), a transcription factor that mediates several inflammatory pathways was reduced in hMSC treated pigs compared to controls (p = 0.04). There was no significant difference in lung injury, assessed by histological scoring in hMSC treated pigs versus controls (p = 0.063). There was no difference in neutrophil counts between hMSC-treated pigs and controls. Within 4 h, there was no difference in the levels of IL-10 and IL-8 pre- and post-treatment with hMSC. In addition, there was no difference in hemodynamics, lung mechanics or arterial blood gases between hMSC treated animals and controls. Subsequent studies are required to determine if the observed decrease in inflammatory transcription factors will translate into improvement in inflammation and in physiological parameters over the long term.

AB - © 2016 The Authors. Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a major cause of global morbidity and mortality. Mesenchymal stem cells (MSC) have shown promise in treating inflammatory lung conditions. We hypothesised that human MSC (hMSC) can improve ALI/ARDS through their anti-inflammatory actions. We subjected pigs (n = 6) to intravenous oleic acid (OA) injury, ventilation and hMSC infusion, while the controls (n = 5) had intravenous OA, ventilation and an infusion vehicle control. hMSC were infused 1 h after the administration of OA. The animals were monitored for additional 4 h. Nuclear translocation of nuclear factor-light chain enhancer of activated B cells (NF-κB), a transcription factor that mediates several inflammatory pathways was reduced in hMSC treated pigs compared to controls (p = 0.04). There was no significant difference in lung injury, assessed by histological scoring in hMSC treated pigs versus controls (p = 0.063). There was no difference in neutrophil counts between hMSC-treated pigs and controls. Within 4 h, there was no difference in the levels of IL-10 and IL-8 pre- and post-treatment with hMSC. In addition, there was no difference in hemodynamics, lung mechanics or arterial blood gases between hMSC treated animals and controls. Subsequent studies are required to determine if the observed decrease in inflammatory transcription factors will translate into improvement in inflammation and in physiological parameters over the long term.

U2 - 10.1016/j.scr.2016.05.005

DO - 10.1016/j.scr.2016.05.005

M3 - Article

VL - 17

SP - 25

EP - 31

JO - Stem Cell Research

JF - Stem Cell Research

SN - 1873-5061

IS - 1

ER -